Atlanta Consulting Group Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Atlanta Consulting Group Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$173K	Hold	10,000	–	–	0.03%	185
2026 Q1	$124K	Hold	10,000	–	–	0.03%	143
2025 Q4	$126K	Hold	10,000	–	–	0.03%	160
2025 Q3	$100K	Hold	10,000	–	–	0.02%	144
2025 Q2	$80.9K	Hold	10,000	–	–	0.02%	131
2025 Q1	$83.8K	Hold	10,000	–	–	0.02%	122
2024 Q4	$79.2K	Hold	10,000	–	–	0.03%	129
2024 Q3	$83.2K	Hold	10,000	–	–	0.02%	227
2024 Q2	$63.5K	Hold	10,000	–	–	0.01%	115
2024 Q1	$60.6K	Buy	+10,000	New	+$56.4K	0.02%	131

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Atlanta Consulting Group Advisors's AMRX Position: Q2 2026 in Review

Atlanta Consulting Group Advisors held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 10,000 shares worth $173K. The position accounts for 0.03% of the portfolio, ranked #185.

Atlanta Consulting Group Advisors first reported a position in AMRX in Q1 2024 and has held it in 10 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Atlanta Consulting Group Advisors held 10,000 shares of Amneal Pharmaceuticals worth $173K as of Q2 2026.
Atlanta Consulting Group Advisors left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
Amneal Pharmaceuticals made up 0.03% of Atlanta Consulting Group Advisors's portfolio in Q2 2026, its #185 holding.
Atlanta Consulting Group Advisors first reported a position in Amneal Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.